Humira vs Stelara
Adalimumab vs Ustekinumab · Comparison Guide
Quick Comparison
| Feature | Humira | Stelara |
|---|---|---|
| Generic Name | Adalimumab | Ustekinumab |
| Manufacturer | AbbVie | Janssen |
| Drug Class | TNF-alpha Inhibitor | IL-12/23 Inhibitor |
| Shared Conditions | Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis | |
Key Differences: Humira vs Stelara
Stelara requires only 4 injections per year (after loading dose) vs. 26 for Humira. For Crohn's and UC, both are effective first-line biologics; gastroenterologists often prefer Stelara for its favorable safety profile. For psoriasis, Stelara and Humira are both approved but newer IL-23 inhibitors have largely superseded both.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Stelara (Ustekinumab)
- Class: IL-12/23 Inhibitor
- Manufacturer: Janssen
- Full Stelara information →
Stelara requires only 4 injections per year (after loading dose) vs. 26 for Humira. For Crohn's and UC, both are effective first-line biologics; gastroenterologists often prefer Stelara for its favorable safety profile. For psoriasis, Stelara and Humira are both approved but newer IL-23 inhibitors have largely superseded both.
Neither Humira nor Stelara is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Stelara are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Stelara both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Stelara
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Stelara should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.